{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q38424",
      "entity_text" : "ALT",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10407" ],
      "TissueType" : [ "tissuelist:TS-0923" ]
    }
  },
  "verbose_text" : "Patients with hepatic decompensation (Child-Pugh category B or C), and a history of hepatic decompensation, as well as patients before and after liver transplantation with detectable HBV-DNA, are eligible for prompt and indefinite ETV (at 1.0 mg) or TDF treatment regardless of their ALT level.",
  "reading_complete" : "2020-08-03T18:26:01Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T18:20:40Z",
  "trigger" : "level",
  "evidence" : [ "ALT level" ],
  "pmc_id" : "5497479",
  "score" : 0
}